The 2013 National Eye Institutes five year AREDS 2 study (Age-Related Eye Disease Study) proved that a revised formula consisting of the AREDS formula without beta-carotene, adding lutein and zeaxanthin reduces the risk of progression of Age-Related Macular Degeneration by an additional eighteen percent compared to those in the AREDS 2 study who took the original recommended formula from 2001.
The subset of participants that took lutein and zeaxanthin and no beta-carotene reduced their risk of developing advanced stages of AMD by 18% compared to the those in AREDS 2 who took the original supplement with beta carotene. Furthermore the study showed that in 5 years the participants that took the new formula to have less risk of progression of AMD than the people that took the original formula. In fact, the AREDS 2 formula information proved to decrease the risk by 18 percent.
This website provides valuable educational information on the AREDS 2 study results, the suggested vitamin formula for optimal results in fighting age-related macular degeneration (AMD), and where you can find customer recommended AREDS 2 Formula products. Please select a link to find out more.
|
|
